MoneyWorks4Me

Neuland Laboratories reports Profit after tax of Rs 98.41 Mln, in the June 2022 quarter

03 Aug 2022 Evaluate
The revenue for the June 2022 quarter is pegged at Rs. 2211.70 millions, about 10.10% up against Rs. 2008.87 millions recorded during the year-ago period.Net profit stood at Rs. 98.41  millions  compared to Rs. 86.48 millions in the corresponding previous quarter,high by 13.80%.OP of the company witnessed a marginal growth to 289.90 millions from 276.58 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 2211.70 2008.87 10.10 2211.70 2008.87 10.10 9510.77 9369.13 1.51
Other Income 5.12 20.56 -75.10 5.12 20.56 -75.10 20.77 160.95 -87.10
PBIDT 289.90 276.58 4.82 289.90 276.58 4.82 1442.70 1625.38 -11.24
Interest 28.58 38.43 -25.63 28.58 38.43 -25.63 134.94 178.98 -24.61
PBDT 261.32 238.15 9.73 261.32 238.15 9.73 1307.76 1446.40 -9.59
Depreciation 127.98 118.28 8.20 127.98 118.28 8.20 490.36 396.78 23.58
PBT 133.34 119.87 11.24 133.34 119.87 11.24 817.40 1049.62 -22.12
TAX 34.93 33.39 4.61 34.93 33.39 4.61 182.06 246.67 -26.19
Deferred Tax -6.07 0.13 -4769.23 -6.07 0.13 -4769.23 -22.16 121.84 -118.19
PAT 98.41 86.48 13.80 98.41 86.48 13.80 635.34 802.95 -20.87
Equity 129.00 129.00 0.00 129.00 129.00 0.00 129.00 129.00 0.00
PBIDTM(%) 13.11 13.77 -4.80 13.11 13.77 -4.80 15.17 17.35 -12.56
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..